Across CCLE and GDSC cell-line panels, response to Oxaliplatin is significantly associated with the pathway activity of multiple pathways, with BLOOD_Myeloma cell lines showing a particularly strong set of associations.
The most reproducible Oxaliplatin response-associated pathways across cancer lineages are Proteinogenic amino acid metabolic process, Purine ribonucleoside monophosphate biosynthetic process, and Endosomal transport, each associated with drug response in up to 10 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, Oxaliplatin response versus Proteinogenic amino acid metabolic process pathway activity in BLOOD_Myeloma (Pearson r = 0.71).